Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | RORC | P51449 | 1/20 | 0.36 |
| ▸ | PDE2A | O00408 | 2/20 | 0.36 |
| ▸ | EIF4A3 | P38919 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.31 |
| ▸ | ANPEP | P15144 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.30 |
| ▸ | HTR2B | P41595 | 2/20 | 0.30 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22306685 | 0.87 | TSHR (0.50) | TSHRRORCGABRA1GABRB2GABRG2 | |
| SCHEMBL19629265 | 0.84 | TSHR (0.42) | TSHRRORCPDE2A | |
| SCHEMBL12374304 | 0.83 | TSHR (0.41) | TSHRRORCPDE2A | |
| SCHEMBL12173269 | 0.83 | EIF4A3 (0.41) | TSHRPDE2AEIF4A3GABRA1GABRB2 | |
| SCHEMBL17429416 | 0.81 | TSHR (0.53) | TSHRRORCGABRA1GABRB2ADRA1A | |
| SCHEMBL26081489 | 0.77 | TSHR (0.39) | TSHRRORCPDE2ALMNASLC6A2 | |
| SCHEMBL20622503 | 0.76 | EIF4A3 (0.40) | PDE2AEIF4A3GABRA1GABRG2GABRB3 | |
| SCHEMBL26860328 | 0.75 | TSHR (0.38) | TSHRRORCPDE2A | |
| SCHEMBL20097032 | 0.75 | TSHR (0.38) | TSHRRORCPDE2AHTR2C | |
| SCHEMBL27548299 | 0.75 | TSHR (0.38) | TSHRRORCPDE2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160222295-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL COMPOSITION EMPLOYING THE SAME | DAXIN MATERIALS CORPORATION (TW) | 2016-08-04 | — | — | US | disclosed |
| US-20160024384-A1 | LIQUID-CRYSTAL COMPOUND, LIQUID-CRYSTAL COMPOSITION AND LIQUID-CRYSTAL DISPLAY DEVICE | DAXIN MATERIALS CORPORATION (TW) | 2016-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160222295-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL COMPOSITION EMPLOYING THE SAME | ZYX, MLX, NPM1 | TSHR 3085/4885RORC 3854/4885PDE2A 3367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.